Genetic Engineering News: Breaking Genetic Engineering News, Comments and Articles.

19:53 EST 22nd November 2014 | BioPortfolio

Genetic Engineering NewsRSS

Read the latest Genetic Engineering News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Genetic Engineering.

Search or Follow Our Genetic Engineering News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Genetic Engineering News.

Showing "genetic engineering genetics" News Articles 1 to 25 of 7,600+

Friday 21st November 2014

3D printed microrobots could be used as drug delivery vessels, and more

Here’s another tech to file in the “boundless possibility of 3D printing” category: Two Swiss engineering professors are developing microscopic robots that will work inside the body to transport cargo...

Praxair Prices €500 Million of 1.625% Notes Due 2025

Praxair, Inc. (NYSE: PX) has priced €500 million of 1.625% notes due December 1, 2025. The notes are being offered under its shelf registration statement filed with the U.S. Securities and Exchange Commission. The offering is led by Citigroup Global Markets Limited, Deutsche Bank AG, London Branch, HSBC Bank plc and Merrill Lynch International. ...

Woodcock: Breakthrough designation mostly about efficacy

FDA awards or denies breakthrough designation requests primarily based on convincing clinical evidence of substantial efficacy or lack thereof, Janet Woodcock said Friday at a conference organized by Friends of Cancer Research and the Brookings Insti...

22nd Century Group to Hold Conference Call to Provide Business Update For Investors

22nd Century Group, Inc. (NYSE MKT:XXII) announced today that Henry Sicignano III, President and Chief Operating Officer of 22nd Century Group, together with Richard M. Sanders, an independent Director of 22nd Century Group, will provide a business update for investors on Tuesday, November 25th at 10:00 AM (EST). The conference call is expe...

Atlas, Novartis lead $15mm Series A financing for Intellia Therapeutics

Intellia Therapeutics Inc. (targeted genome engineering) raised $15mm in a Series A round led by Atlas Venture and Novartis AG.

Genetic Signatures seeks to go public in Australia

Molecular diagnostics firm Genetic Signatures Ltd. filed for its initial public offering on the Australian Stock Exchange.

Vascular Surgeon Dr. Jeffrey Lawson to Address VEITHSymposium

Clinical Work and Data will be presented on Humacyte’s Novel Bioengineered Blood Vessel Jeffrey H. Lawson, M.D., Ph.D, Vice Chair for Research, Professor of Surgery and Pathology at Duke University Medical Center (Durham, North Carolina), Director of the Vascular Research Laboratory and Director of Clinical Trials for the Department of Surgery, will ...

Restoring Vision with Stem Cells

The National Eye Institute (NEI), a division of the National Institutes of Health, has awarded researchers at the Icahn School of Medicine at Mount Sinai a five-year grant totaling $1 million that will support an effort to re-create a patients' ocula...

Genetic Test for Eye Disorders Proves Very Effective

GEDi proves more sensitive than exome sequencingRead more about Genetic Test for Eye Disorders Proves Very EffectiveComments

Researchers use evolutionary principles to model cancer mutations

Moffitt Cancer Center researchers are taking a unique approach to understanding and investigating cancer by utilising evolutionary principles and computational modelling to examine the role of specific genetic mutations in the Darwinian struggle amon...

AstraZeneca Announces Plans to Expand its Frederick, Maryland Biologics Manufacturing Center

$200+ Million Investment to Support Company’s Maturing Biologics Pipeline AstraZeneca today announced plans to expand its biologics manufacturing center in Frederick, Md. The more than $200 million project will increase production capacity at the facility to support AstraZeneca’s maturing pipeline, and will help position the company to keep pace wi...

Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd

Genetic Rx Boston Boston, MA (PRWEB) November 21, 2014 Prominent academics, leaders of the biopharmaceutical industry and key investors will gather on December 3rd at Genetic Rx, a networking conference of the Boston Biotech Conferences series. GeneticRx will take place at the Joseph B. Martin Conference Center at Harvard Medical School and will discuss the present and future of genetic medicines...

After Embryo Checks for Genetic Defects, Twin Joy for Chennai Woman

(Times of India) – In a unique technique that could boost the success of in-vitro fertilization (IVF) procedures, a fertility centre in the city helped Divya deliver a pair of twins after testing the embryo for genetic defects before implanting...

European Metropolitan Area of Munich Is Top Location for Biotechnology and Pharmaceutical Industries

New study by the Chamber of Industry and Commerce (IHK), the City of Munich and BioM confirms the importance of this sector Munich, Germany, November 21, 2014 / B3C newswire / - The biotech sector in the Greater Munich area continues to demonstrate significant growth in revenue and staff numbers despite ever-increasing international competition. This continues Munich's status as one of the pre-em...

More Genetic Clues Found in a Severe Food Allergy

PHILADELPHIA, Nov. 21, 2014 /PRNewswire-USNewswire/ -- Scientists have identified four new genes associated with the severe food allergy eosinophilic esophagitis (EoE). Because the genes appear to have roles in other allergic diseases and in inflammation, the findings may point toward potential new treatments for EoE. "This research adds to the evidence that genetic factors play key roles in EoE,...

LabCorp Completes Acquisition of LIPOSCIENCE

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced the completion of its acquisition of LIPOSCIENCE, Inc. (NASDAQ:LPDX), effective November 20, 2014. At a special meeting held on November 20, 2014, LIPOSCIENCE’s stockholders approved the acquisition and the transaction closed promptly thereafter. After the close ...

CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales

ORLANDO, Fla., Nov. 21, 2014 /PRNewswire/ -- MEDITE Group acquired by CytoCore, Inc. (OTCBB: CYOE) on April 4, 2014 reported nine months and the 3rd quarter sales ended September 30, 2014 of $8.7 million and $2.8 million. Operating income was $448,000 for the nine months ended September 2014 and a $38,000 loss for the quarter ended September 2014. "Even though our 3rd quarter is usually a seasonab...

Collagen Solutions To Acquire Leading NZ Based Providers of Medical Grade Collagen for £6 Million

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, today announced the proposed acquisition of New Zealand based Southern Lights Biomaterials) for a total maximum consideration of NZ$12m (c. £6m) in cash and shares. The acquisiti...

Data Companies Carve Out Niche In DNA Test Interpretation

For more than a decade researchers have been unleashing a deluge of information about the role of genes in disease, based on automated sequencing of DNA. Genetic tests on individual patients are slowly becoming more common, more detailed, and less co...

News and press releases: Cerdelga recommended for approval in type 1 Gaucher disease

New oral treatment option for rare debilitating genetic disease

New Periodic Fever Syndrome ID'd

(MedPage Today) -- Another genetic autoinflammatory disease identified by NIH researchers.

BRIEF-Regulator resumes review of Zhongyuan Union Cell's assets restructuring plan

Nov 21 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd

Engineers discover new method to determine surface properties at the nanoscale

Engineering researchers at Texas Tech University have developed a method for characterizing the surface properties of materials at different temperatures at the nanoscale.

University of Maryland Breaks Ground for A. James Clark Hall

COLLEGE PARK, Md., Nov. 21, 2014 /PRNewswire-USNewswire/ -- The University of Maryland's A. James Clark School of Engineering today will host the ceremonial groundbreaking of the new A. James Clark Hall at the University of Maryland, College Park. The new building will cultivate transformative new engineering and biomedical technologies to accelerate advancements in human health.  Takin...

Researchers hope their work will help predict which dogs may get a deadly disease

Veterinary researchers at Cummings School are teaming with scientists at Harvard, MIT and Nestlé Purina PetCare to decipher the genetics of bloat, a common cause of death in large dogs.

Search BioPortfolio:

News Quicklinks